APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Growth Hormone Deficiency (Ghd) Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Human Growth Hormone Deficiency (Ghd) Drug Market Analysis and Forecast 2026-2032

30 December 2025206 pages

Choose your research edition.

Industry ResearchHuman Growth Hormone Deficiency (Ghd) Drug Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Growth Hormone Deficiency (Ghd) Drug Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Human Growth Hormone Deficiency (Ghd) Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Growth Hormone Deficiency (Ghd) Drug Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Growth Hormone Deficiency (Ghd) Drug Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Human Growth Hormone Deficiency (Ghd) Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Human Growth Hormone Deficiency (Ghd) Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Human Growth Hormone Deficiency (Ghd) Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Human Growth Hormone Deficiency (Ghd) Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Human Growth Hormone Deficiency (Ghd) Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Human Growth Hormone Deficiency (Ghd) Drug include Teva Pharmaceutical Industries, Ltd, Merck KGaA, Eli Lilly and Company, Versartis Inc., Strongbridge Biopharma, Sandoz International GmbH (Novartis AG), Pfizer Inc, Opko Health, Inc. and Novo Nordisk A/S, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Human Growth Hormone Deficiency (Ghd) Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Human Growth Hormone Deficiency (Ghd) Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Human Growth Hormone Deficiency (Ghd) Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Human Growth Hormone Deficiency (Ghd) Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Human Growth Hormone Deficiency (Ghd) Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Human Growth Hormone Deficiency (Ghd) Drug sales, projected growth trends, production technology, application and end-user industry.

Human Growth Hormone Deficiency (Ghd) Drug Segment by Company

Teva Pharmaceutical Industries, Ltd

Merck KGaA

Eli Lilly and Company

Versartis Inc.

Strongbridge Biopharma

Sandoz International GmbH (Novartis AG)

Pfizer Inc

Opko Health, Inc.

Novo Nordisk A/S

LG Life Sciences

Ipsen S.A.

GeneScience Pharmaceuticals Co. Ltd

Genentech, Inc (Roche)

Ferring Pharmaceuticals

EMD Serono Inc.

Ascendis Pharma A/S

AnkeBio Co. Ltd

Human Growth Hormone Deficiency (Ghd) Drug Segment by Type

Somavaratan

Somapacitan

TransCon-hGH

Others

Human Growth Hormone Deficiency (Ghd) Drug Segment by Application

Children

Adults

Human Growth Hormone Deficiency (Ghd) Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Growth Hormone Deficiency (Ghd) Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Growth Hormone Deficiency (Ghd) Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Growth Hormone Deficiency (Ghd) Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Human Growth Hormone Deficiency (Ghd) Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Human Growth Hormone Deficiency (Ghd) Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Growth Hormone Deficiency (Ghd) Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Human Growth Hormone Deficiency (Ghd) Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Somavaratan Major Manufacturers Table 3. Somapacitan Major Manufacturers Table 4. TransCon-hGH Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Human Growth Hormone Deficiency (Ghd) Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Children Major Manufacturers Table 8. Adults Major Manufacturers Table 9. Human Growth Hormone Deficiency (Ghd) Drug Industry Trends Table 10. Human Growth Hormone Deficiency (Ghd) Drug Industry Drivers Table 11. Human Growth Hormone Deficiency (Ghd) Drug Industry Opportunities and Challenges Table 12. Human Growth Hormone Deficiency (Ghd) Drug Industry Restraints Table 13. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue Market Share by Region (2021-2026) Table 17. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue Market Share by Region (2027-2032) Table 18. Global Human Growth Hormone Deficiency (Ghd) Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Region (2021-2026) & (K Units) Table 20. Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Region (2027-2032) & (K Units) Table 21. Global Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share by Region (2021-2026) Table 22. Global Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share by Region (2027-2032) Table 23. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share by Manufacturers (2021-2026) Table 27. Global Human Growth Hormone Deficiency (Ghd) Drug Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Human Growth Hormone Deficiency (Ghd) Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Human Growth Hormone Deficiency (Ghd) Drug Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Human Growth Hormone Deficiency (Ghd) Drug Manufacturers, Product Type & Application Table 31. Global Human Growth Hormone Deficiency (Ghd) Drug Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Human Growth Hormone Deficiency (Ghd) Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue Market Share by Type (2021-2026) Table 38. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue Market Share by Type (2027-2032) Table 39. Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2021-2026) & (K Units) Table 41. Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2027-2032) & (K Units) Table 42. Global Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share by Type (2021-2026) Table 43. Global Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share by Type (2027-2032) Table 44. Global Human Growth Hormone Deficiency (Ghd) Drug Price by Type (2021-2026) & (US$/Unit) Table 45. Global Human Growth Hormone Deficiency (Ghd) Drug Price by Type (2027-2032) & (US$/Unit) Table 46. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue Market Share by Application (2021-2026) Table 50. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue Market Share by Application (2027-2032) Table 51. Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2021-2026) & (K Units) Table 53. Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2027-2032) & (K Units) Table 54. Global Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share by Application (2021-2026) Table 55. Global Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share by Application (2027-2032) Table 56. Global Human Growth Hormone Deficiency (Ghd) Drug Price by Application (2021-2026) & (US$/Unit) Table 57. Global Human Growth Hormone Deficiency (Ghd) Drug Price by Application (2027-2032) & (US$/Unit) Table 58. Teva Pharmaceutical Industries, Ltd Company Information Table 59. Teva Pharmaceutical Industries, Ltd Business Overview Table 60. Teva Pharmaceutical Industries, Ltd Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Teva Pharmaceutical Industries, Ltd Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio Table 62. Teva Pharmaceutical Industries, Ltd Recent Development Table 63. Merck KGaA Company Information Table 64. Merck KGaA Business Overview Table 65. Merck KGaA Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Merck KGaA Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio Table 67. Merck KGaA Recent Development Table 68. Eli Lilly and Company Company Information Table 69. Eli Lilly and Company Business Overview Table 70. Eli Lilly and Company Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Eli Lilly and Company Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio Table 72. Eli Lilly and Company Recent Development Table 73. Versartis Inc. Company Information Table 74. Versartis Inc. Business Overview Table 75. Versartis Inc. Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Versartis Inc. Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio Table 77. Versartis Inc. Recent Development Table 78. Strongbridge Biopharma Company Information Table 79. Strongbridge Biopharma Business Overview Table 80. Strongbridge Biopharma Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Strongbridge Biopharma Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio Table 82. Strongbridge Biopharma Recent Development Table 83. Sandoz International GmbH (Novartis AG) Company Information Table 84. Sandoz International GmbH (Novartis AG) Business Overview Table 85. Sandoz International GmbH (Novartis AG) Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Sandoz International GmbH (Novartis AG) Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio Table 87. Sandoz International GmbH (Novartis AG) Recent Development Table 88. Pfizer Inc Company Information Table 89. Pfizer Inc Business Overview Table 90. Pfizer Inc Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Pfizer Inc Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio Table 92. Pfizer Inc Recent Development Table 93. Opko Health, Inc. Company Information Table 94. Opko Health, Inc. Business Overview Table 95. Opko Health, Inc. Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Opko Health, Inc. Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio Table 97. Opko Health, Inc. Recent Development Table 98. Novo Nordisk A/S Company Information Table 99. Novo Nordisk A/S Business Overview Table 100. Novo Nordisk A/S Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Novo Nordisk A/S Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio Table 102. Novo Nordisk A/S Recent Development Table 103. LG Life Sciences Company Information Table 104. LG Life Sciences Business Overview Table 105. LG Life Sciences Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. LG Life Sciences Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio Table 107. LG Life Sciences Recent Development Table 108. Ipsen S.A. Company Information Table 109. Ipsen S.A. Business Overview Table 110. Ipsen S.A. Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Ipsen S.A. Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio Table 112. Ipsen S.A. Recent Development Table 113. GeneScience Pharmaceuticals Co. Ltd Company Information Table 114. GeneScience Pharmaceuticals Co. Ltd Business Overview Table 115. GeneScience Pharmaceuticals Co. Ltd Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. GeneScience Pharmaceuticals Co. Ltd Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio Table 117. GeneScience Pharmaceuticals Co. Ltd Recent Development Table 118. Genentech, Inc (Roche) Company Information Table 119. Genentech, Inc (Roche) Business Overview Table 120. Genentech, Inc (Roche) Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Genentech, Inc (Roche) Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio Table 122. Genentech, Inc (Roche) Recent Development Table 123. Ferring Pharmaceuticals Company Information Table 124. Ferring Pharmaceuticals Business Overview Table 125. Ferring Pharmaceuticals Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Ferring Pharmaceuticals Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio Table 127. Ferring Pharmaceuticals Recent Development Table 128. EMD Serono Inc. Company Information Table 129. EMD Serono Inc. Business Overview Table 130. EMD Serono Inc. Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. EMD Serono Inc. Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio Table 132. EMD Serono Inc. Recent Development Table 133. Ascendis Pharma A/S Company Information Table 134. Ascendis Pharma A/S Business Overview Table 135. Ascendis Pharma A/S Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Ascendis Pharma A/S Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio Table 137. Ascendis Pharma A/S Recent Development Table 138. AnkeBio Co. Ltd Company Information Table 139. AnkeBio Co. Ltd Business Overview Table 140. AnkeBio Co. Ltd Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. AnkeBio Co. Ltd Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio Table 142. AnkeBio Co. Ltd Recent Development Table 143. North America Human Growth Hormone Deficiency (Ghd) Drug Revenue by Type (2021-2026) & (US$ Million) Table 144. North America Human Growth Hormone Deficiency (Ghd) Drug Revenue by Type (2027-2032) & (US$ Million) Table 145. North America Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2021-2026) & (K Units) Table 146. North America Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2027-2032) & (K Units) Table 147. North America Human Growth Hormone Deficiency (Ghd) Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 148. North America Human Growth Hormone Deficiency (Ghd) Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 149. North America Human Growth Hormone Deficiency (Ghd) Drug Revenue by Application (2021-2026) & (US$ Million) Table 150. North America Human Growth Hormone Deficiency (Ghd) Drug Revenue by Application (2027-2032) & (US$ Million) Table 151. North America Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2021-2026) & (K Units) Table 152. North America Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2027-2032) & (K Units) Table 153. North America Human Growth Hormone Deficiency (Ghd) Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 154. North America Human Growth Hormone Deficiency (Ghd) Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 155. North America Human Growth Hormone Deficiency (Ghd) Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 156. North America Human Growth Hormone Deficiency (Ghd) Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 157. North America Human Growth Hormone Deficiency (Ghd) Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 158. North America Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 159. North America Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2021-2026) & (K Units) Table 160. North America Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2027-2032) & (K Units) Table 161. North America Human Growth Hormone Deficiency (Ghd) Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 162. North America Human Growth Hormone Deficiency (Ghd) Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 163. United States Human Growth Hormone Deficiency (Ghd) Drug Revenue (2021-2032) & (US$ Million) Table 164. Canada Human Growth Hormone Deficiency (Ghd) Drug Revenue (2021-2032) & (US$ Million) Table 165. Europe Human Growth Hormone Deficiency (Ghd) Drug Revenue by Type (2021-2026) & (US$ Million) Table 166. Europe Human Growth Hormone Deficiency (Ghd) Drug Revenue by Type (2027-2032) & (US$ Million) Table 167. Europe Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2021-2026) & (K Units) Table 168. Europe Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2027-2032) & (K Units) Table 169. Europe Human Growth Hormone Deficiency (Ghd) Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 170. Europe Human Growth Hormone Deficiency (Ghd) Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 171. Europe Human Growth Hormone Deficiency (Ghd) Drug Revenue by Application (2021-2026) & (US$ Million) Table 172. Europe Human Growth Hormone Deficiency (Ghd) Drug Revenue by Application (2027-2032) & (US$ Million) Table 173. Europe Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2021-2026) & (K Units) Table 174. Europe Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2027-2032) & (K Units) Table 175. Europe Human Growth Hormone Deficiency (Ghd) Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 176. Europe Human Growth Hormone Deficiency (Ghd) Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 177. Europe Human Growth Hormone Deficiency (Ghd) Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 178. Europe Human Growth Hormone Deficiency (Ghd) Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 179. Europe Human Growth Hormone Deficiency (Ghd) Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 180. Europe Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 181. Europe Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2021-2026) & (K Units) Table 182. Europe Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2027-2032) & (K Units) Table 183. Europe Human Growth Hormone Deficiency (Ghd) Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 184. Europe Human Growth Hormone Deficiency (Ghd) Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 185. Germany Human Growth Hormone Deficiency (Ghd) Drug Revenue (2021-2032) & (US$ Million) Table 186. France Human Growth Hormone Deficiency (Ghd) Drug Revenue (2021-2032) & (US$ Million) Table 187. U.K. Human Growth Hormone Deficiency (Ghd) Drug Revenue (2021-2032) & (US$ Million) Table 188. Italy Human Growth Hormone Deficiency (Ghd) Drug Revenue (2021-2032) & (US$ Million) Table 189. Netherlands Human Growth Hormone Deficiency (Ghd) Drug Revenue (2021-2032) & (US$ Million) Table 190. China Human Growth Hormone Deficiency (Ghd) Drug Revenue by Type (2021-2026) & (US$ Million) Table 191. China Human Growth Hormone Deficiency (Ghd) Drug Revenue by Type (2027-2032) & (US$ Million) Table 192. China Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2021-2026) & (K Units) Table 193. China Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2027-2032) & (K Units) Table 194. China Human Growth Hormone Deficiency (Ghd) Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 195. China Human Growth Hormone Deficiency (Ghd) Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 196. China Human Growth Hormone Deficiency (Ghd) Drug Revenue by Application (2021-2026) & (US$ Million) Table 197. China Human Growth Hormone Deficiency (Ghd) Drug Revenue by Application (2027-2032) & (US$ Million) Table 198. China Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2021-2026) & (K Units) Table 199. China Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2027-2032) & (K Units) Table 200. China Human Growth Hormone Deficiency (Ghd) Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 201. China Human Growth Hormone Deficiency (Ghd) Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 202. Asia Human Growth Hormone Deficiency (Ghd) Drug Revenue by Type (2021-2026) & (US$ Million) Table 203. Asia Human Growth Hormone Deficiency (Ghd) Drug Revenue by Type (2027-2032) & (US$ Million) Table 204. Asia Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2021-2026) & (K Units) Table 205. Asia Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2027-2032) & (K Units) Table 206. Asia Human Growth Hormone Deficiency (Ghd) Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 207. Asia Human Growth Hormone Deficiency (Ghd) Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 208. Asia Human Growth Hormone Deficiency (Ghd) Drug Revenue by Application (2021-2026) & (US$ Million) Table 209. Asia Human Growth Hormone Deficiency (Ghd) Drug Revenue by Application (2027-2032) & (US$ Million) Table 210. Asia Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2021-2026) & (K Units) Table 211. Asia Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2027-2032) & (K Units) Table 212. Asia Human Growth Hormone Deficiency (Ghd) Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 213. Asia Human Growth Hormone Deficiency (Ghd) Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 214. Asia Human Growth Hormone Deficiency (Ghd) Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 215. Asia Human Growth Hormone Deficiency (Ghd) Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 216. Asia Human Growth Hormone Deficiency (Ghd) Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 217. Asia Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 218. Asia Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2021-2026) & (K Units) Table 219. Asia Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2027-2032) & (K Units) Table 220. Asia Human Growth Hormone Deficiency (Ghd) Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 221. Asia Human Growth Hormone Deficiency (Ghd) Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 222. Japan Human Growth Hormone Deficiency (Ghd) Drug Revenue (2021-2032) & (US$ Million) Table 223. South Korea Human Growth Hormone Deficiency (Ghd) Drug Revenue (2021-2032) & (US$ Million) Table 224. India Human Growth Hormone Deficiency (Ghd) Drug Revenue (2021-2032) & (US$ Million) Table 225. Australia Human Growth Hormone Deficiency (Ghd) Drug Revenue (2021-2032) & (US$ Million) Table 226. China Taiwan Human Growth Hormone Deficiency (Ghd) Drug Revenue (2021-2032) & (US$ Million) Table 227. Southeast Asia Human Growth Hormone Deficiency (Ghd) Drug Revenue (2021-2032) & (US$ Million) Table 228. SAMEA Human Growth Hormone Deficiency (Ghd) Drug Revenue by Type (2021-2026) & (US$ Million) Table 229. SAMEA Human Growth Hormone Deficiency (Ghd) Drug Revenue by Type (2027-2032) & (US$ Million) Table 230. SAMEA Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2021-2026) & (K Units) Table 231. SAMEA Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2027-2032) & (K Units) Table 232. SAMEA Human Growth Hormone Deficiency (Ghd) Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 233. SAMEA Human Growth Hormone Deficiency (Ghd) Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 234. SAMEA Human Growth Hormone Deficiency (Ghd) Drug Revenue by Application (2021-2026) & (US$ Million) Table 235. SAMEA Human Growth Hormone Deficiency (Ghd) Drug Revenue by Application (2027-2032) & (US$ Million) Table 236. SAMEA Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2021-2026) & (K Units) Table 237. SAMEA Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2027-2032) & (K Units) Table 238. SAMEA Human Growth Hormone Deficiency (Ghd) Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 239. SAMEA Human Growth Hormone Deficiency (Ghd) Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 240. SAMEA Human Growth Hormone Deficiency (Ghd) Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 241. SAMEA Human Growth Hormone Deficiency (Ghd) Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 242. SAMEA Human Growth Hormone Deficiency (Ghd) Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 243. SAMEA Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 244. SAMEA Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2021-2026) & (K Units) Table 245. SAMEA Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2027-2032) & (K Units) Table 246. SAMEA Human Growth Hormone Deficiency (Ghd) Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 247. SAMEA Human Growth Hormone Deficiency (Ghd) Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 248. Brazil Human Growth Hormone Deficiency (Ghd) Drug Revenue (2021-2032) & (US$ Million) Table 249. Argentina Human Growth Hormone Deficiency (Ghd) Drug Revenue (2021-2032) & (US$ Million) Table 250. Chile Human Growth Hormone Deficiency (Ghd) Drug Revenue (2021-2032) & (US$ Million) Table 251. Colombia Human Growth Hormone Deficiency (Ghd) Drug Revenue (2021-2032) & (US$ Million) Table 252. Peru Human Growth Hormone Deficiency (Ghd) Drug Revenue (2021-2032) & (US$ Million) Table 253. Saudi Arabia Human Growth Hormone Deficiency (Ghd) Drug Revenue (2021-2032) & (US$ Million) Table 254. Israel Human Growth Hormone Deficiency (Ghd) Drug Revenue (2021-2032) & (US$ Million) Table 255. UAE Human Growth Hormone Deficiency (Ghd) Drug Revenue (2021-2032) & (US$ Million) Table 256. Turkey Human Growth Hormone Deficiency (Ghd) Drug Revenue (2021-2032) & (US$ Million) Table 257. Iran Human Growth Hormone Deficiency (Ghd) Drug Revenue (2021-2032) & (US$ Million) Table 258. Egypt Human Growth Hormone Deficiency (Ghd) Drug Revenue (2021-2032) & (US$ Million) Table 259. Key Raw Materials Table 260. Raw Materials Key Suppliers Table 261. Human Growth Hormone Deficiency (Ghd) Drug Distributors List Table 262. Human Growth Hormone Deficiency (Ghd) Drug Customers List Table 263. Research Programs/Design for This Report Table 264. Authors List of This Report Table 265. Secondary Sources Table 266. Primary Sources List of Figures Figure 1. Human Growth Hormone Deficiency (Ghd) Drug Image Figure 2. Global Human Growth Hormone Deficiency (Ghd) Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Growth Hormone Deficiency (Ghd) Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Somavaratan Image Figure 5. Somapacitan Image Figure 6. TransCon-hGH Image Figure 7. Others Image Figure 8. Global Human Growth Hormone Deficiency (Ghd) Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Human Growth Hormone Deficiency (Ghd) Drug Market Size Share 2021 VS 2025 VS 2032 Figure 10. Children Image Figure 11. Adults Image Figure 12. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue (2021-2032) & (US$ Million) Figure 14. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue Market Share by Region (2021-2032) Figure 17. Global Human Growth Hormone Deficiency (Ghd) Drug Sales (2021-2032) & (K Units) Figure 18. Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Human Growth Hormone Deficiency (Ghd) Drug Sales YoY (2021-2032) & (K Units) Figure 21. Europe Human Growth Hormone Deficiency (Ghd) Drug Sales YoY (2021-2032) & (K Units) Figure 22. China Human Growth Hormone Deficiency (Ghd) Drug Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Human Growth Hormone Deficiency (Ghd) Drug Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Sales YoY (2021-2032) & (K Units) Figure 25. Global Human Growth Hormone Deficiency (Ghd) Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Human Growth Hormone Deficiency (Ghd) Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue Market Share by Type (2021-2032) Figure 31. Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share by Type (2021-2032) Figure 34. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue Market Share by Application (2021-2032) Figure 37. Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share by Application (2021-2032) Figure 40. North America Human Growth Hormone Deficiency (Ghd) Drug Revenue Share by Type (2021-2032) Figure 41. North America Human Growth Hormone Deficiency (Ghd) Drug Sales Share by Type (2021-2032) Figure 42. North America Human Growth Hormone Deficiency (Ghd) Drug Revenue Share by Application (2021-2032) Figure 43. North America Human Growth Hormone Deficiency (Ghd) Drug Sales Share by Application (2021-2032) Figure 44. North America Human Growth Hormone Deficiency (Ghd) Drug Revenue Share by Country (2021-2032) Figure 45. North America Human Growth Hormone Deficiency (Ghd) Drug Sales Share by Country (2021-2032) Figure 46. Europe Human Growth Hormone Deficiency (Ghd) Drug Revenue Share by Type (2021-2032) Figure 47. Europe Human Growth Hormone Deficiency (Ghd) Drug Sales Share by Type (2021-2032) Figure 48. Europe Human Growth Hormone Deficiency (Ghd) Drug Revenue Share by Application (2021-2032) Figure 49. Europe Human Growth Hormone Deficiency (Ghd) Drug Sales Share by Application (2021-2032) Figure 50. Europe Human Growth Hormone Deficiency (Ghd) Drug Revenue Share by Country (2021-2032) Figure 51. Europe Human Growth Hormone Deficiency (Ghd) Drug Sales Share by Country (2021-2032) Figure 52. China Human Growth Hormone Deficiency (Ghd) Drug Revenue Share by Type (2021-2032) Figure 53. China Human Growth Hormone Deficiency (Ghd) Drug Sales Share by Type (2021-2032) Figure 54. China Human Growth Hormone Deficiency (Ghd) Drug Revenue Share by Application (2021-2032) Figure 55. China Human Growth Hormone Deficiency (Ghd) Drug Sales Share by Application (2021-2032) Figure 56. Asia Human Growth Hormone Deficiency (Ghd) Drug Revenue Share by Type (2021-2032) Figure 57. Asia Human Growth Hormone Deficiency (Ghd) Drug Sales Share by Type (2021-2032) Figure 58. Asia Human Growth Hormone Deficiency (Ghd) Drug Revenue Share by Application (2021-2032) Figure 59. Asia Human Growth Hormone Deficiency (Ghd) Drug Sales Share by Application (2021-2032) Figure 60. Asia Human Growth Hormone Deficiency (Ghd) Drug Revenue Share by Country (2021-2032) Figure 61. Asia Human Growth Hormone Deficiency (Ghd) Drug Sales Share by Country (2

Scope & coverage.

Types
  • Somavaratan
  • Somapacitan
  • TransCon-hGH
  • Others
Applications
  • Children
  • Adults
Companies covered
  • Teva Pharmaceutical Industries, Ltd
  • Merck KGaA
  • Eli Lilly and Company
  • Versartis Inc.
  • Strongbridge Biopharma
  • Sandoz International GmbH (Novartis AG)
  • Pfizer Inc
  • Opko Health, Inc.
  • Novo Nordisk A/S
  • LG Life Sciences
  • Ipsen S.A.
  • GeneScience Pharmaceuticals Co. Ltd
  • Genentech, Inc (Roche)
  • Ferring Pharmaceuticals
  • EMD Serono Inc.
  • Ascendis Pharma A/S
  • AnkeBio Co. Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Human Growth Hormone Deficiency (Ghd) Drug Market by Type
  3. 1.2.1 Global Human Growth Hormone Deficiency (Ghd) Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Somavaratan
  5. 1.2.3 Somapacitan
  6. 1.2.4 TransCon-hGH
  7. 1.2.5 Others
  8. 1.3 Human Growth Hormone Deficiency (Ghd) Drug Market by Application
  9. 1.3.1 Global Human Growth Hormone Deficiency (Ghd) Drug Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Children
  11. 1.3.3 Adults
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Human Growth Hormone Deficiency (Ghd) Drug Market Dynamics
  1. 2.1 Human Growth Hormone Deficiency (Ghd) Drug Industry Trends
  2. 2.2 Human Growth Hormone Deficiency (Ghd) Drug Industry Drivers
  3. 2.3 Human Growth Hormone Deficiency (Ghd) Drug Industry Opportunities and Challenges
  4. 2.4 Human Growth Hormone Deficiency (Ghd) Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Human Growth Hormone Deficiency (Ghd) Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Human Growth Hormone Deficiency (Ghd) Drug Revenue by Region
  3. 3.2.1 Global Human Growth Hormone Deficiency (Ghd) Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Human Growth Hormone Deficiency (Ghd) Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Human Growth Hormone Deficiency (Ghd) Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Human Growth Hormone Deficiency (Ghd) Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Human Growth Hormone Deficiency (Ghd) Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Region
  9. 3.4.1 Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Human Growth Hormone Deficiency (Ghd) Drug Revenue by Manufacturers
  2. 4.1.1 Global Human Growth Hormone Deficiency (Ghd) Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Human Growth Hormone Deficiency (Ghd) Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Human Growth Hormone Deficiency (Ghd) Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Manufacturers
  6. 4.2.1 Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Human Growth Hormone Deficiency (Ghd) Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Human Growth Hormone Deficiency (Ghd) Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Human Growth Hormone Deficiency (Ghd) Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Human Growth Hormone Deficiency (Ghd) Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Human Growth Hormone Deficiency (Ghd) Drug Manufacturers, Product Type & Application
  13. 4.7 Global Human Growth Hormone Deficiency (Ghd) Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Human Growth Hormone Deficiency (Ghd) Drug Market CR5 and HHI
  16. 4.8.2 2025 Human Growth Hormone Deficiency (Ghd) Drug Tier 1, Tier 2, and Tier 3
5 Human Growth Hormone Deficiency (Ghd) Drug Market by Type
  1. 5.1 Global Human Growth Hormone Deficiency (Ghd) Drug Revenue by Type
  2. 5.1.1 Global Human Growth Hormone Deficiency (Ghd) Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Human Growth Hormone Deficiency (Ghd) Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Human Growth Hormone Deficiency (Ghd) Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Type
  6. 5.2.1 Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Human Growth Hormone Deficiency (Ghd) Drug Price by Type
6 Human Growth Hormone Deficiency (Ghd) Drug Market by Application
  1. 6.1 Global Human Growth Hormone Deficiency (Ghd) Drug Revenue by Application
  2. 6.1.1 Global Human Growth Hormone Deficiency (Ghd) Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Human Growth Hormone Deficiency (Ghd) Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Human Growth Hormone Deficiency (Ghd) Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Application
  6. 6.2.1 Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Human Growth Hormone Deficiency (Ghd) Drug Price by Application
7 Company Profiles
  1. 7.1 Teva Pharmaceutical Industries, Ltd
  2. 7.1.1 Teva Pharmaceutical Industries, Ltd Company Information
  3. 7.1.2 Teva Pharmaceutical Industries, Ltd Business Overview
  4. 7.1.3 Teva Pharmaceutical Industries, Ltd Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Pharmaceutical Industries, Ltd Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
  6. 7.1.5 Teva Pharmaceutical Industries, Ltd Recent Developments
  7. 7.2 Merck KGaA
  8. 7.2.1 Merck KGaA Company Information
  9. 7.2.2 Merck KGaA Business Overview
  10. 7.2.3 Merck KGaA Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck KGaA Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
  12. 7.2.5 Merck KGaA Recent Developments
  13. 7.3 Eli Lilly and Company
  14. 7.3.1 Eli Lilly and Company Company Information
  15. 7.3.2 Eli Lilly and Company Business Overview
  16. 7.3.3 Eli Lilly and Company Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Eli Lilly and Company Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
  18. 7.3.5 Eli Lilly and Company Recent Developments
  19. 7.4 Versartis Inc.
  20. 7.4.1 Versartis Inc. Company Information
  21. 7.4.2 Versartis Inc. Business Overview
  22. 7.4.3 Versartis Inc. Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Versartis Inc. Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
  24. 7.4.5 Versartis Inc. Recent Developments
  25. 7.5 Strongbridge Biopharma
  26. 7.5.1 Strongbridge Biopharma Company Information
  27. 7.5.2 Strongbridge Biopharma Business Overview
  28. 7.5.3 Strongbridge Biopharma Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Strongbridge Biopharma Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
  30. 7.5.5 Strongbridge Biopharma Recent Developments
  31. 7.6 Sandoz International GmbH (Novartis AG)
  32. 7.6.1 Sandoz International GmbH (Novartis AG) Company Information
  33. 7.6.2 Sandoz International GmbH (Novartis AG) Business Overview
  34. 7.6.3 Sandoz International GmbH (Novartis AG) Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Sandoz International GmbH (Novartis AG) Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
  36. 7.6.5 Sandoz International GmbH (Novartis AG) Recent Developments
  37. 7.7 Pfizer Inc
  38. 7.7.1 Pfizer Inc Company Information
  39. 7.7.2 Pfizer Inc Business Overview
  40. 7.7.3 Pfizer Inc Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Pfizer Inc Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
  42. 7.7.5 Pfizer Inc Recent Developments
  43. 7.8 Opko Health, Inc.
  44. 7.8.1 Opko Health, Inc. Company Information
  45. 7.8.2 Opko Health, Inc. Business Overview
  46. 7.8.3 Opko Health, Inc. Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Opko Health, Inc. Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
  48. 7.8.5 Opko Health, Inc. Recent Developments
  49. 7.9 Novo Nordisk A/S
  50. 7.9.1 Novo Nordisk A/S Company Information
  51. 7.9.2 Novo Nordisk A/S Business Overview
  52. 7.9.3 Novo Nordisk A/S Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Novo Nordisk A/S Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
  54. 7.9.5 Novo Nordisk A/S Recent Developments
  55. 7.10 LG Life Sciences
  56. 7.10.1 LG Life Sciences Company Information
  57. 7.10.2 LG Life Sciences Business Overview
  58. 7.10.3 LG Life Sciences Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 LG Life Sciences Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
  60. 7.10.5 LG Life Sciences Recent Developments
  61. 7.11 Ipsen S.A.
  62. 7.11.1 Ipsen S.A. Company Information
  63. 7.11.2 Ipsen S.A. Business Overview
  64. 7.11.3 Ipsen S.A. Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Ipsen S.A. Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
  66. 7.11.5 Ipsen S.A. Recent Developments
  67. 7.12 GeneScience Pharmaceuticals Co. Ltd
  68. 7.12.1 GeneScience Pharmaceuticals Co. Ltd Company Information
  69. 7.12.2 GeneScience Pharmaceuticals Co. Ltd Business Overview
  70. 7.12.3 GeneScience Pharmaceuticals Co. Ltd Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 GeneScience Pharmaceuticals Co. Ltd Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
  72. 7.12.5 GeneScience Pharmaceuticals Co. Ltd Recent Developments
  73. 7.13 Genentech, Inc (Roche)
  74. 7.13.1 Genentech, Inc (Roche) Company Information
  75. 7.13.2 Genentech, Inc (Roche) Business Overview
  76. 7.13.3 Genentech, Inc (Roche) Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Genentech, Inc (Roche) Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
  78. 7.13.5 Genentech, Inc (Roche) Recent Developments
  79. 7.14 Ferring Pharmaceuticals
  80. 7.14.1 Ferring Pharmaceuticals Company Information
  81. 7.14.2 Ferring Pharmaceuticals Business Overview
  82. 7.14.3 Ferring Pharmaceuticals Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Ferring Pharmaceuticals Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
  84. 7.14.5 Ferring Pharmaceuticals Recent Developments
  85. 7.15 EMD Serono Inc.
  86. 7.15.1 EMD Serono Inc. Company Information
  87. 7.15.2 EMD Serono Inc. Business Overview
  88. 7.15.3 EMD Serono Inc. Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 EMD Serono Inc. Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
  90. 7.15.5 EMD Serono Inc. Recent Developments
  91. 7.16 Ascendis Pharma A/S
  92. 7.16.1 Ascendis Pharma A/S Company Information
  93. 7.16.2 Ascendis Pharma A/S Business Overview
  94. 7.16.3 Ascendis Pharma A/S Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Ascendis Pharma A/S Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
  96. 7.16.5 Ascendis Pharma A/S Recent Developments
  97. 7.17 AnkeBio Co. Ltd
  98. 7.17.1 AnkeBio Co. Ltd Company Information
  99. 7.17.2 AnkeBio Co. Ltd Business Overview
  100. 7.17.3 AnkeBio Co. Ltd Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 AnkeBio Co. Ltd Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
  102. 7.17.5 AnkeBio Co. Ltd Recent Developments
8 North America
  1. 8.1 North America Human Growth Hormone Deficiency (Ghd) Drug Market Size by Type
  2. 8.1.1 North America Human Growth Hormone Deficiency (Ghd) Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Human Growth Hormone Deficiency (Ghd) Drug Price by Type (2021-2032)
  5. 8.2 North America Human Growth Hormone Deficiency (Ghd) Drug Market Size by Application
  6. 8.2.1 North America Human Growth Hormone Deficiency (Ghd) Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Human Growth Hormone Deficiency (Ghd) Drug Price by Application (2021-2032)
  9. 8.3 North America Human Growth Hormone Deficiency (Ghd) Drug Market Size by Country
  10. 8.3.1 North America Human Growth Hormone Deficiency (Ghd) Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Human Growth Hormone Deficiency (Ghd) Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Human Growth Hormone Deficiency (Ghd) Drug Market Size by Type
  2. 9.1.1 Europe Human Growth Hormone Deficiency (Ghd) Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Human Growth Hormone Deficiency (Ghd) Drug Price by Type (2021-2032)
  5. 9.2 Europe Human Growth Hormone Deficiency (Ghd) Drug Market Size by Application
  6. 9.2.1 Europe Human Growth Hormone Deficiency (Ghd) Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Human Growth Hormone Deficiency (Ghd) Drug Price by Application (2021-2032)
  9. 9.3 Europe Human Growth Hormone Deficiency (Ghd) Drug Market Size by Country
  10. 9.3.1 Europe Human Growth Hormone Deficiency (Ghd) Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Human Growth Hormone Deficiency (Ghd) Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Human Growth Hormone Deficiency (Ghd) Drug Market Size by Type
  2. 10.1.1 China Human Growth Hormone Deficiency (Ghd) Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2021-2032)
  4. 10.1.3 China Human Growth Hormone Deficiency (Ghd) Drug Price by Type (2021-2032)
  5. 10.2 China Human Growth Hormone Deficiency (Ghd) Drug Market Size by Application
  6. 10.2.1 China Human Growth Hormone Deficiency (Ghd) Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2021-2032)
  8. 10.2.3 China Human Growth Hormone Deficiency (Ghd) Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Human Growth Hormone Deficiency (Ghd) Drug Market Size by Type
  2. 11.1.1 Asia Human Growth Hormone Deficiency (Ghd) Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Human Growth Hormone Deficiency (Ghd) Drug Price by Type (2021-2032)
  5. 11.2 Asia Human Growth Hormone Deficiency (Ghd) Drug Market Size by Application
  6. 11.2.1 Asia Human Growth Hormone Deficiency (Ghd) Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Human Growth Hormone Deficiency (Ghd) Drug Price by Application (2021-2032)
  9. 11.3 Asia Human Growth Hormone Deficiency (Ghd) Drug Market Size by Country
  10. 11.3.1 Asia Human Growth Hormone Deficiency (Ghd) Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Human Growth Hormone Deficiency (Ghd) Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Human Growth Hormone Deficiency (Ghd) Drug Market Size by Type
  2. 12.1.1 SAMEA Human Growth Hormone Deficiency (Ghd) Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Human Growth Hormone Deficiency (Ghd) Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Human Growth Hormone Deficiency (Ghd) Drug Market Size by Application
  6. 12.2.1 SAMEA Human Growth Hormone Deficiency (Ghd) Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Human Growth Hormone Deficiency (Ghd) Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Human Growth Hormone Deficiency (Ghd) Drug Market Size by Country
  10. 12.3.1 SAMEA Human Growth Hormone Deficiency (Ghd) Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Human Growth Hormone Deficiency (Ghd) Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Human Growth Hormone Deficiency (Ghd) Drug Value Chain Analysis
  2. 13.1.1 Human Growth Hormone Deficiency (Ghd) Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Human Growth Hormone Deficiency (Ghd) Drug Production Mode & Process
  6. 13.2 Human Growth Hormone Deficiency (Ghd) Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Human Growth Hormone Deficiency (Ghd) Drug Distributors
  9. 13.2.3 Human Growth Hormone Deficiency (Ghd) Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst